MitoVerde

What is the Seed and Soil Hypothesis in cancer?

The Seed and Soil Hypothesis is a classic concept in cancer biology that explains how and where metastasis occurs. Proposed by British surgeon Stephen Paget in 1889, it suggests that cancer cells (the "seeds") can only grow and form secondary tumors in environments (the "soil") that are favorable for their survival and growth (Paget, 1889).

Not all tissues in the body are equally receptive to metastatic cancer cells. For example, breast cancer often spreads to bones, while prostate cancer commonly metastasizes to the spine. This isn’t just a matter of blood flow—it’s because certain organs provide the right biochemical and structural conditions for specific cancer cells to thrive.

The “soil” includes many factors:

Growth factors and cytokines that support tumor growth.
Blood supply, which delivers oxygen and nutrients.
Extracellular matrix components, which help cancer cells anchor and grow.
Immune cell behavior, which may either suppress or support metastasis.

This hypothesis shifted the way scientists view metastasis—from being a random event to a highly selective process influenced by both cancer cell properties and the microenvironment of distant tissues.

Modern research supports this idea, showing that cancer cells often prepare the "soil" in advance by releasing signals that modify target tissues. This is known as pre-metastatic niche formation (Kaplan et al., 2005).

Understanding the seed and soil relationship helps guide new treatments aimed at altering the “soil” to make it inhospitable for metastatic cells, rather than targeting the “seeds” alone.

References:
Paget, S. (1889). The distribution of secondary growths in cancer of the breast. Lancet, 133(3421), 571–573.
Kaplan, R. N., Riba, R. D., Zacharoulis, S., et al. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature, 438(7069), 820–827.

What is cancer metastasis, and how does it happen?
Metastasis is the process by which cancer cells spread from the original (primary) tumor to other parts of the body. It’s one of the most dangerous features of cancer and the leading cause of cancer-related deaths (Steeg, 2006).
For a cancer to metastasize, it must overcome several biological barriers. First, cells from the primary tumor break away and invade surrounding tissues. They then enter the bloodstream or lymphatic system—a step known as intravasation. Once in circulation, most cancer cells die due to immune attack or physical stress, but a few survive, travel through the body, and exit into new tissues (extravasation), where they may form secondary tumors.
Metastatic cells aren’t just passengers—they adapt. They often change shape, lose adhesion to neighboring cells, and express enzymes like matrix metalloproteinases (MMPs) that help them break through tissue barriers (Hanahan & Weinberg, 2011). These cells may also alter their metabolism to survive in foreign environments.
The most common sites of metastasis are the lungs, liver, bones, and brain, depending on the type of cancer. For example, breast cancer often spreads to bone, while colon cancer tends to metastasize to the liver.
At the molecular level, metastasis is driven by a complex mix of genetic mutations, signaling pathways, and interactions with the tumor microenvironment. The epithelial-to-mesenchymal transition (EMT) is a key mechanism that enables cancer cells to become more mobile and invasive.
Metastasis makes cancer much harder to treat, which is why early detection and targeted therapies are critical in modern oncology.
References:
Steeg, P. S. (2006). Tumor metastasis: mechanistic insights and clinical challenges. Nature Medicine, 12(8), 895–904.
Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144(5), 646–674

What are tumors, and what role do tumor suppressor genes play?
A tumor is an abnormal mass of cells that forms when cells grow and divide more than they should—or don’t die when they should. Tumors can be benign (non-cancerous) or malignant (cancerous). Benign tumors remain localized and usually don’t pose a major threat, but malignant tumors invade surrounding tissues and can spread to other parts of the body through the bloodstream or lymphatic system (Weinberg, 2013).
At the genetic level, tumor formation often begins with the failure of genes that normally keep cell growth in check. These are known as tumor suppressor genes.
Tumor suppressor genes act like the cell’s braking system. They monitor cell division, repair DNA errors, and trigger apoptosis (programmed cell death) when something goes wrong. When these genes are mutated or inactivated, the brakes are lost—and cells can start growing uncontrollably.
One of the most well-known tumor suppressor genes is TP53, which encodes the p53 protein. This protein responds to DNA damage by pausing the cell cycle or initiating cell death if the damage is too great. Mutations in TP53 are found in over half of all human cancers (Levine, 1997).
Other examples include:
RB1, which regulates the cell cycle in retinal and other cells
BRCA1/BRCA2, which help repair DNA damage, especially in breast and ovarian tissue

Unlike oncogenes, where a single mutated copy can drive cancer, tumor suppressor genes usually require both copies to be inactivated—one inherited or mutated first, and the second often lost later through additional mutations or deletions. This concept is known as the "two-hit hypothesis" (Knudson, 1971).
Understanding tumor suppressor genes is key to early detection, genetic screening, and the development of targeted therapies.
References:
Weinberg, R. A. (2013). The Biology of Cancer (2nd ed.). Garland Science.
Levine, A. J. (1997). p53, the cellular gatekeeper for growth and division. Cell, 88(3), 323–331.
Knudson, A. G. (1971). Mutation and cancer: statistical study of retinoblastoma. Proceedings of the National Academy of Sciences, 68(4), 820–823.

What is a mutation, and why does it matter?
A mutation is a permanent change in the DNA sequence of a gene. Since DNA carries the instructions for building and maintaining cells, even a small change can alter how a cell functions. Some mutations have little or no effect, while others can disrupt vital processes or lead to diseases, including cancer (Alberts et al., 2015).
Mutations can happen for various reasons:
Spontaneous mutations occur naturally during DNA replication.
Induced mutations result from external factors like radiation, chemicals, or viruses.

At the molecular level, mutations can take several forms:
Point mutations change a single base (e.g., A to G)
Insertions or deletions add or remove bases, which can shift the reading frame
Chromosomal mutations affect large sections of DNA or entire chromosomes

Some mutations are inherited from parents, while others are acquired over a lifetime. If a mutation occurs in a reproductive cell, it can be passed to the next generation. But if it happens in a somatic (non-reproductive) cell, it can accumulate and contribute to disease in the individual.
Not all mutations are harmful. Some are neutral, and a few even confer advantages—such as resistance to infections or environmental stress. Evolution itself depends on beneficial mutations being passed on over generations.
But when mutations hit critical genes—like tumor suppressors or proto-oncogenes—they can drive uncontrolled cell growth and lead to cancer. This is why mutation control and DNA repair are essential parts of cellular life.
Reference:
Alberts, B., Johnson, A., Lewis, J., et al. (2015). Molecular Biology of the Cell (6th ed.). Garland Science.

What are oncogenes, and how do they relate to cancer?
Oncogenes are mutated or overactive versions of normal genes called proto-oncogenes—genes that usually help regulate healthy cell growth and division. But when a proto-oncogene is altered, it can become permanently switched “on,” pushing the cell to divide uncontrollably. This uncontrolled growth is a major step toward cancer (Weinberg, 2013).
Under normal conditions, proto-oncogenes play essential roles in development, tissue repair, and signaling pathways. They’re like the gas pedal of the cell cycle—helping cells grow when needed. But when that gas pedal gets stuck, even without a green light, the cell keeps accelerating. That’s essentially what happens when a proto-oncogene turns into an oncogene.
How do proto-oncogenes become oncogenes?
Point mutations can increase their activity
Gene amplification can cause too many copies to be produced
Chromosomal translocations can place them under the control of hyperactive promoters

A well-known example is the RAS gene, which, when mutated, keeps sending growth signals even when none are present. Mutant RAS proteins are found in a large number of cancers, including pancreatic and colorectal cancers (Cox & Der, 2010).
But oncogenes alone aren’t usually enough to cause cancer. They often work in combination with other mutations—like the inactivation of tumor suppressor genes—to push the cell further down the path toward malignancy.
References:
Weinberg, R. A. (2013). The Biology of Cancer (2nd ed.). Garland Science.
Cox, A. D., & Der, C. J. (2010). Ras history: The saga continues. Small GTPases, 1(1), 2–27.

What is cancer, really?
We hear about cancer all the time, but what is it at the cellular level?
Cancer begins when normal cells lose control over how they grow and divide. Under normal circumstances, cells follow a highly regulated cycle—they divide only when necessary, repair damage when needed, and die (through apoptosis) when their job is done. But in cancer, this regulation breaks down. Cells begin to divide uncontrollably, refuse to die, and sometimes invade nearby tissues or spread to distant parts of the body—a process known as metastasis (Hanahan & Weinberg, 2000).
What causes this to happen? Cancer is usually triggered by mutations in key genes. These may be:
Oncogenes: mutated forms of normal genes (proto-oncogenes) that push the cell to divide too much
Tumor suppressor genes: whose job is to slow down division or repair DNA—when they're faulty, cells grow unchecked
DNA repair genes: mutations here mean errors go uncorrected, leading to more mutations over time
Cancer isn't just one disease. There are hundreds of types, depending on which cells are affected—like lung cancer, breast cancer, or leukemia. Each behaves differently and requires a specific approach to diagnosis and treatment.
Importantly, not all tumors are cancerous. Benign tumors don’t spread, while malignant tumors do.
So, cancer is essentially the result of a breakdown in the rules that keep cells behaving properly.
Reference:
Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100(1), 57–70.

What are enzymes, and why do we need them?

Enzymes are biological molecules—mostly proteins—that act as catalysts, speeding up chemical reactions in the body without being used up themselves. They’re essential to everything from digestion to DNA replication (Berg et al., 2002).

Each enzyme has a specific job. For example, amylase breaks down carbohydrates in your saliva, lipase helps digest fats, and DNA polymerase copies genetic material during cell division. What makes enzymes so effective is their ability to lower the activation energy needed for a reaction to occur. Without them, even basic processes would be far too slow to sustain life.

In humans, enzymes are central to metabolism, energy production, detoxification, and immune function. If an enzyme doesn’t work properly—or is missing entirely—it can lead to serious health issues. Take lactose intolerance, for instance: it’s caused by a lack of the enzyme lactase, which is needed to break down milk sugar.

Ever wonder why high fevers affect how your body works? Enzymes are sensitive to temperature and pH. When conditions aren’t right, they lose shape and stop working.

So, the next time you digest food or take a breath, remember—enzymes are quietly running the show.

What Is the Central Dogma of Life? The Flow of Genetic Information:
At the heart of all life lies a fundamental principle that explains how cells store, express, and pass on genetic information: the central dogma of molecular biology. First proposed by Francis Crick in 1958, the central dogma describes the unidirectional flow of genetic information—from DNA to RNA to protein (Crick, 1970).
This concept forms the foundation of molecular biology and explains how genotype becomes phenotype, or in simpler terms, how the instructions in your DNA lead to the traits and functions that define living organisms.
Here’s how it works:
1. DNA Replication
Before anything else, DNA must be replicated so that genetic information is passed from cell to cell during division. Each strand of the double helix serves as a template to create a new complementary strand. This ensures genetic continuity.
2. Transcription: DNA → RNA
In this step, the information in DNA is transcribed into a molecule of messenger RNA (mRNA). An enzyme called RNA polymerase reads the DNA template and synthesizes a complementary RNA strand. This mRNA carries the genetic message from the nucleus to the cytoplasm in eukaryotic cells (Lodish et al., 2000).
3. Translation: RNA → Protein
Once in the cytoplasm, ribosomes read the mRNA sequence in sets of three bases called codons. Each codon specifies an amino acid, and the ribosome links these amino acids together to form a protein. This step is known as translation. The sequence of amino acids determines the protein’s structure and function.
In essence, the central dogma tells us that DNA makes RNA, and RNA makes protein. Proteins, in turn, are responsible for the vast majority of cellular structure and activity—from enzymes and hormones to antibodies and structural components.
While the central dogma is mostly linear, there are exceptions:
Reverse transcription (as seen in retroviruses like HIV), where RNA is converted back into DNA.
Non-coding RNAs that function without being translated, like tRNAs and microRNAs.
Still, the central dogma remains the guiding framework for understanding molecular biology. It's not just a concept—it’s the molecular choreography of life.

Why Do Primers Bind to the 3′ End? Understanding DNA Directionality in PCR:
If you’ve worked with PCR or any DNA-based technique, you’ve probably heard it over and over: primers bind at the 3′ end of DNA strands. But why exactly is that? The answer lies in the fundamental chemistry of DNA synthesis—and the way DNA polymerases operate (Alberts et al., 2002).
To understand this, we need to look at DNA’s structure. DNA strands have directionality, meaning each strand has a 5′ (five-prime) end and a 3′ (three-prime) end. These terms refer to the carbon atoms in the DNA’s sugar backbone. During synthesis, new nucleotides can only be added to the 3′ hydroxyl (-OH) group of the growing DNA strand.
Here’s where primers come in.
During PCR, two primers are used:
1. The forward primer binds to the 3′ end of the antisense strand (which runs 3′ to 5′), so that synthesis can proceed in the 5′ to 3′ direction.
2. The reverse primer binds to the 3′ end of the sense strand (which runs 5′ to 3′), again allowing synthesis in the 5′ to 3′ direction.

Why Only 5′ to 3′?
DNA polymerase is a very particular enzyme—it can’t synthesize DNA in the 3′ to 5′ direction. It requires a free 3′-OH group to attach the incoming nucleotides. That’s why primers must bind to the 3′ end of the template strand: they provide the starting point with the correct orientation for the polymerase to do its job.

This has a few critical implications:
1. Primer orientation matters: If a primer is placed in the wrong direction, it won’t allow extension and no product will be formed.
2. Design is directional: Primers must be written and ordered in the 5′ to 3′ direction, even though they bind to a complementary 3′ to 5′ strand.

In short, primers bind to the 3′ end of the DNA template because DNA polymerase can only add nucleotides in the 5′ to 3′ direction, and it must build upon a primer that already has a free 3′-OH.
So next time you're designing primers, remember: it’s not just tradition—it’s biochemistry.

What Is a Primer and How Does It Work in PCR?
When it comes to copying DNA in the lab, one small tool plays a giant role: the primer. In molecular biology, primers are short, single-stranded DNA sequences—usually around 18 to 25 nucleotides long—that are designed to bind to specific regions of DNA. They serve as the starting point for DNA synthesis, especially during Polymerase Chain Reaction (PCR) (Mullis & Faloona, 1987).
In PCR, two primers are used:
1. Forward primer: binds to the 3' end of one DNA strand
2. Reverse primer: binds to the 3' end of the complementary strand

This setup defines the exact boundaries of the DNA region that will be amplified. Once the primers are attached, the enzyme Taq polymerase can extend from the primers to build new DNA strands.

How Primers Work: Step by Step
During PCR, the primer’s role is activated in the annealing step, when the reaction cools down enough for primers to find and bind to their complementary DNA sequences. They must match the target DNA exactly—otherwise, binding fails, and no amplification occurs.
Once attached, Taq polymerase recognizes the primer-template junction and begins adding nucleotides (dNTPs) to the 3' end of the primer. This is why primers are essential: DNA polymerase can’t start from scratch—it needs a primer to initiate synthesis.

Primer Design: A Critical Task
Good primer design is key to specific and successful PCR. A well-designed primer should:
1. Have a GC content of 40–60% for stable binding
2. Avoid secondary structures like hairpins or dimers
3. Have a melting temperature (Tm) between 50–65°C
4. Be specific to the target sequence, with minimal off-target matches

For applications like qPCR, primers are often paired with probes to add specificity and enable quantification.
Primers aren’t just used in PCR—they’re also vital for DNA sequencing, mutagenesis, and cloning. In every case, they act as precise bookmarks that tell the polymerase where to begin.
So, while small in size, primers carry a big responsibility: they guide the whole reaction, ensuring that only the desired DNA region is copied—accurately, efficiently, and repeatedly.

What Is Nucleic Acid Extraction and Why Is It the First Step in Molecular Biology?
Before PCR, gel electrophoresis, or sequencing can begin, there's one critical first step: nucleic acid extraction. Whether you're studying DNA or RNA, this process isolates pure genetic material from cells, tissues, or environmental samples—laying the foundation for nearly every molecular technique that follows (Green & Sambrook, 2012).
At its core, nucleic acid extraction is about breaking open cells and separating nucleic acids from everything else—proteins, lipids, and cellular debris—without degrading the genetic material in the process.

Here's how it works:
1. Sample Collection and Cell Lysis:
Samples may come from blood, bacteria, plants, or swabs. Cells are lysed using chemical buffers, enzymes (like proteinase K or lysozyme), or mechanical disruption (e.g., bead beating). This step breaks open the plasma and nuclear membranes, releasing DNA or RNA into solution.
2. Removal of Proteins and Contaminants:
Proteins are removed using phenol-chloroform extraction or binding buffers in column-based kits. Enzymatic treatments like RNase or DNase may be used to selectively eliminate either RNA or DNA if needed.
3. Precipitation or Binding of Nucleic Acids:
In traditional methods, alcohol (ethanol or isopropanol) is added to precipitate DNA/RNA, which is then pelleted by centrifugation. In silica-column or magnetic bead methods, nucleic acids bind to a solid matrix and are washed to remove impurities.
4. Elution and Purity Check:
Finally, the nucleic acid is eluted into a clean buffer or water. The purity and concentration are often assessed using spectrophotometry (e.g., measuring A260/A280 ratios) or fluorometric methods.

Why is this step so important? Because poor extraction leads to degraded, contaminated, or low-yield nucleic acids, which can compromise downstream applications like PCR, qPCR, or sequencing. In clinical labs, for example, clean extraction is vital for accurate pathogen detection or mutation analysis.
Modern kits have made extraction fast and standardized, but the principles remain rooted in classic molecular biology. Whether you're isolating plasmids, genomic DNA, or total RNA, quality extraction is where good science begins.